Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G
Top Cited Papers
Open Access
- 1 September 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (38), 32618-32624
- https://doi.org/10.1074/jbc.m504942200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Polymorphisms affecting gene regulation and mRNA processing: Broad implications for pharmacogeneticsPharmacology & Therapeutics, 2004
- Allelic expression imbalance of the human CYP3A4 gene and individual phenotypic statusHuman Molecular Genetics, 2004
- The genomics of gene expressionGenomics, 2004
- Evolutionary changes in cis and trans gene regulationNature, 2004
- Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central SwedenMolecular Psychiatry, 2004
- Effect of the A118G polymorphism on binding affinity, potency and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu‐opioid receptorJournal of Neurochemistry, 2004
- Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamicsNature Reviews Molecular Cell Biology, 2004
- A genetic association study of the mu opioid receptor and severe opioid dependencePsychiatric Genetics, 2003
- Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European‐AmericansAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2003
- Cocaine, Dopamine and the Endogenous Opioid SystemJournal of Addictive Diseases, 1996